The global esophageal implant market size is estimated to reach US$ 147.0 million in 2023. From 2023 to 2033, global esophageal implant sales are projected to soar at 6.7% CAGR. By the end of 2033, total market value is likely to exceed US$ 280.2 million.
Implants used to treat various esophageal disorders such as gastroesophageal reflux disease (GERD) and esophageal strictures are referred to as esophageal implants. These include esophageal stents, artificial esophageal valves, magnetic sphincter augmentation devices, and injectable bulking agents.
Usage of esophageal implants significantly improves the quality of life in patients suffering from esophageal problems. This is due to their ability to relieve various symptoms and reduce need for medical therapies (acid pills, etc.).
The market growth is being propelled due to the rising need for surgical resection of the esophagus as a result of cancer, trauma, or birth defects.
As per the Centers for Disease Control and Prevention, around one child suffers from esophageal atresia in every 4,100 children born in the United States. This birth condition can occur on its own, although it is more commonly associated with other birth problems. Such escalating faults are important drivers fueling market expansion.
Esophageal implants have emerged as the most effective treatment for a variety of illnesses, including GERD and esophageal strictures. As a result of the increasing efficacy of these implants in therapies, the demand for esophageal implants is increasing.
Rising patient inclination towards minimally invasive procedures is another key factor that is expected to fuel esophageal implant demand globally. Subsequently, growing popularity of biodegradable stents and hybrid implants is likely to support market expansion.
Leading esophageal implant manufacturers are concentrating on developing new innovative solutions with several advantages. For instance, to treat esophageal atresia and other esophageal disorders, Biostage is developing its Cellspan esophageal implant.
These new implants can significantly improve patient outcomes by potentially simplifying surgical techniques to reduce post-operative complications, enhance quality of life, and enable regeneration of the patient’s own esophagus.
| Attributes | Key Insights |
|---|---|
| Estimated Global Esophageal Implant Market Size (2023) | US$ 147.0 million |
| Projected Esophageal Implant Market Value (2033) | US$ 280.2 million |
| Value-based CAGR (2023 to 2033) | 6.7% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Challenges for Companies /Manufacturers in the Esophageal Implant Industry:
Opportunities in the Esophageal Implant Industry:
Latest Trends in the Esophageal Implant Market:
According to Future Market Insights’ (FMI) latest report, global sales of esophageal implants increase at a CAGR of 5.6% from 2017 to 2022. Total market size reached US$ 139.1 million in 2022.
From 2017 to 2022, the global esophageal implant industry witnessed steady growth due to the rising preference for esophageal implants for treatments.
Initially, surgery was the only option for treating tracheoesophageal fistula (TEF). Although this is still true for benign TEF and other disorders, implantation of esophageal implant is currently the preferred treatment for both malignant and benign TEF when surgery cannot be delayed.
Self-expanding metal stents (SEMS) have been the preferred stent since the mid-1990s, replacing hard plastic prostheses.
Looking ahead, the global esophageal implant industry is expected to rise at a CAGR of 6.7% from 2023 to 2033. During the forecast period, the market size is expected to reach US$ 280.2 million.
Growth in the market is expected to be driven by rising cases of esophageal disorders, innovations in esophageal implants, and a strong desire for minimally invasive procedures.
Introduction of several medical innovations and rising demand for implants & therapies involving minimally invasive surgery will further boost the market.
Principal Consultant
Growing Awareness Regarding Treatment of Esophageal Disorders Fueling Demand in the United States
| Country | United States |
|---|---|
| Market Size (US$ million) by End of Forecast Period (2033) | US$ 105.2 million |
| CAGR % from 2023 to End of Forecast (2033) | 7.3% |
As per Future Market Insights (FMI), the United States esophageal implant industry is expected to reach a valuation of US$ 105.2 million by 2033. From 2023 to 2033, esophageal implant sales in the country are likely to surge at 7.3% CAGR.
The United States esophageal implant industry is predicted to expand due to the country's high knowledge of esophageal disease management and treatment. This encourages key firms to develop and launch new products, which will ultimately help them expand their market.
Favorable legislation, presence of significant esophageal stent suppliers, new product releases, and the use of cutting-edge technology are other factors boosting the United States market.
Similarly, rising cases of GERD is likely to elevate esophageal implant demand during the projection period.
Prevalence of Esophageal Cancers to Retain High Demand for Esophageal Stents the United Kingdom
| Country | The United Kingdom |
|---|---|
| Market Size (US$ million) by End of Forecast Period (2033) | US$ 14.11 million |
| CAGR % from 2023 to End of Forecast (2033) | 5.6% |
The United Kingdom esophageal implant industry is forecast to attain a valuation of US$ 14.11 million by 2033. Total esophageal implant demand in China is projected to rise at 5.6% CAGR during the forecast period.
Growth in the market is expected to be driven by rising prevalence of esophageal cancer in the country.
Esophageal stents are eventually employed by doctors to open up a blockage caused by cancer. This aids in the relief of symptoms produced by the obstruction.
Increasing Cases of Dysphagia to Bolster Esophageal Implant Sales in China
| Country | China |
|---|---|
| Market Size (US$ million) by End of Forecast Period (2033) | US$ 21.34 million |
| CAGR % from 2023 to End of Forecast (2033) | 8.6% |
As per Future Market Insights (FMI), esophageal implant sales in China are anticipated to soar at 8.6% CAGR through 2033. Total market valuation in China at the end of 2033 is expected to reach US$ 21.34 million.
The esophageal implant industry in China is likely to expand prominently due to the high prevalence of dysphagia.
Dysphagia is becoming more common in China, especially among the elderly and those who have had strokes. To treat this medical condition, esophageal implants such as stents are being used.
Rising Instances of Barrett’s Esophagus Disease to Elevate Esophageal Implant Demand in Japan
| Country | Japan |
|---|---|
| Market Size (US$ million) by End of Forecast Period (2033) | US$ 4.4 million |
| CAGR % from 2023 to End of Forecast (2033) | 7.5% |
Japan esophageal implant industry is estimated to reach a valuation of US$ 4.4 million by 2033. It is likely to thrive at a CAGR of 7.5% during 2023 to 2033. The market in Japan is predicted to expand because of the increasing geriatric population.
Japan has one of the world's leading shares of geriatric population. The risk of esophageal disorders such as esophageal cancer, gastroesophageal reflux disease (GERD), and Barrett's esophagus increase with age. These diseases often necessitate surgery and the use of esophageal implants.
Increasing Government Support for Development of Medical Devices to Boost Korea Market
| Country | South Korea |
|---|---|
| Market Size (US$ million) by End of Forecast Period (2033) | US$ 0.7 million |
| CAGR % from 2023 to End of Forecast (2033) | 6.9% |
The Korea esophageal implant industry is poised to exhibit a CAGR of 6.9% during the projection period. Total market valuation in Korea is projected to reach US$ 0.7 million by 2033.
The market in South Korea is forecast to witness robust growth due to favorable government support for product development. Through different initiatives and funding support, the South Korean government has aggressively fostered the development of the medical device industry.
Financial incentives, research grants, and tax breaks are available to enterprises engaged in medical device research and development. Because of the government's commitment to supporting innovation in the healthcare sector, both domestic and foreign enterprises have invested in medical device development.
Esophageal Stents to Create the Most Profitable Opportunities for Manufacturers
According to Future Market Insights (FMI), esophageal stents segment is expected to dominate the global market. It is likely to thrive at a CAGR of 6.0% from 2023 to 2033, making it a key revenue-generation segment.
Growth of the target segment is driven by rising usage of esophageal stents for treating various conditions due to their less postoperative difficulties.
Esophageal stents have become key tools for palliative treatment of inoperable esophageal malignancies. They are mostly placed in the esophagus to keep blocked areas open. These stents can also be used to treat conditions such as esophageal fistulas, strictures, leaks, and perforations.
Development of advanced stents by manufacturers to lower the operative risks in patients will further boost the target segment.
Leading esophageal implant manufacturers are introducing novel products that are safe and easy to use. For instance, BONASTENT is an esophageal stent product. It has an anatomically adjustable nitinol hook and cross-wire construction. Its outspread and returning forces are appropriate for excellent conformability.
Growing popularity of bioabsorbable stents is another factor that is expected to boost growth of the target segment.
Gastroesophageal Reflux Disease (GERD) Treatment Application to Lead the Market
Application in treatment of gastroesophageal reflux disease (GERD) is expected to dominate the esophageal implant industry, exhibiting a CAGR of 7.4% from 2023 to 2033. This is due to rising prevalence of GERD coupled with increasing usage of esophageal implants for treating this medical condition.
Numerous studies have found that one of the main causes of GERD disease is obesity or excess belly fat. Over 20% of persons in the United States suffer from GERD as a result of being overweight or obese. This in turn is likely to elevate esophageal implant demand during the assessment period.
Hospitals Remain the Leading End User of Esophageal Implants
As per the latest report, hospitals will remain the leading end-users of esophageal implants. The target segment is likely to progress at a CAGR of 7.1% from 2023 to 2033. This is due to the presence of high skilled professionals in the hospitals and rising patient inclination on getting treatments in hospitals.
Hospitals continue to be the most widely used setting for doing minimally invasive procedures for gastrointestinal diseases. The existence of cutting-edge infrastructure and qualified medical personnel is what drives demand for esophageal implants in hospitals.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The esophageal implant industry is highly competitive due to large presence of regional and local players. In such a scenario, companies must adopt effective strategies to stay ahead of the competition.
Key Strategies Adopted by the Players:
Companies are investing rigorously in research and development to introduce new products with enhanced features. Product innovation enables manufacturers to differentiate themselves from their competitors and meet the evolving needs of customers.
Key players in the industry often form strategic alliances, collaborations, and partnerships with other companies to leverage their strengths and expand their reach in the market.
The esophageal implant industry is witnessing significant growth in emerging markets such as China and India. Key esophageal implant manufacturers are expanding their presence in these markets by establishing local manufacturing facilities and strengthening their distribution networks.
Key esophageal implant companies are also adopting mergers and acquisitions to strengthen their market position, expand their portfolio, and gain access to new markets.
Key Players in the Esophageal Implant Industry:
Key Developments in the Esophageal Implant Industry:
| Attribute | Details |
|---|---|
| Estimated Market Size (2023) | US$ 147.0 million |
| Projected Market Size (2033) | US$ 280.2 million |
| Anticipated Growth Rate (2023 to 2033) | 6.7% CAGR |
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2017 to 2022 |
| Market Analysis | US$ million for Value and MT for Volume |
| Key Regions Covered | North America; Latin America; Europe; Asia Pacific; and Middle East and Africa |
| Key Countries Covered | United States, Canada, Mexico, Brazil, Germany, Italy, France, United Kingdom, Spain, BENELUX, Russia, China, Japan, South Korea, India, ASEAN, Australia and New Zealand, Türkiye, South Africa, GCC Countries, Others. |
| Key Segments Covered | Product, Application, End User, and Region |
| Key Companies Profiled | Boston Scientific; Medtronic; Cook Medical; Taewoong Medical; Micro-Tech (Nanjing) Co., Ltd.; Ella-CS; M.I. Tech; Merit Medical; Xlumena Inc.; Olympus Corporation; Johnson & Johnson; Apollo Endosurgery, Inc.; EndoStim; NDO Surgical, Inc; Mederi Therapeutics; Becton Dickenson & Company; Baxter International (Synovis Surgical Innovations) |
The overall market value could be nearly US$ 147 million in 2023.
The global market is projected to retain its growth rate at 6.7% per year through 2033.
Boston, Medtronic, and Cook Medical are the leading suppliers of Esophageal implants.
GERD treatment is the leading segment which is anticipated to follow 7.4% CAGR till 2033.
The United States to retain its top position with 7.3% CAGR through 2033.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
4. Value-Added Insights
4.1. Product Adoption / Usage Analysis
4.2. Product Features/ USP’s
4.3. Technological Roadmap
4.4. Reimbursement Scenario
4.5. Recent Product Approved / Launched
4.6. Regulatory Landscape
4.7. PESTEL Analysis
4.8. Porter’s Analysis
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP Growth Outlook
5.1.2. Global Healthcare Expenditure Outlook
5.1.3. Global Life Expectancy Outlook
5.2. Forecast Factors - Relevance & Impact
5.2.1. Key Player’s Historic Growth
5.2.2. Growing Geriatric Population Rate
5.2.3. Favourable Government Regulations
5.2.4. Rising Demand for Minimally Invasive Surgeries
5.2.5. Technological Advancement
5.2.6. Increasing Prevalence of Oesophageal Cancer
5.2.7. Growing Product Demand For Gastroesophageal Reflux Disease Treatment
5.3. Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. COVID-19 Crisis - Impact Assessment
6.1. COVID-19 and Impact Analysis
6.1.1. By Product
6.1.2. By Application
6.1.3. By End User
6.1.4. By Region
6.2. 2023 Market Scenario
7. Global Market Volume (in Units) Analysis 2017 to 2022 and Forecast, 2023 to 2033
7.1. Historical Volume (in Units) Analysis, 2017 to 2022
7.2. Current and Future Volume (in Units) Projections, 2023 to 2033
7.2.1. Y-o-Y Growth Trend Analysis
8. Global Market - Pricing Analysis
8.1. Regional Pricing Analysis By Product
8.2. Pricing Break-up
8.2.1. Manufacturer-Level Pricing
8.2.2. Distributor Level Pricing
8.3. Global Average Pricing Analysis Benchmark
8.4. Pricing Assumptions
9. Global Market Demand (in Value or Size in US$ million) Analysis 2017 to 2022 and Forecast, 2023 to 2033
9.1. Historical Market Value (US$ Million) Analysis, 2017 to 2022
9.2. Current and Future Market Value (US$ Million) Projections, 2023 to 2033
9.2.1. Y-o-Y Growth Trend Analysis
9.2.2. Absolute $ Opportunity Analysis
10. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Product
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Product, 2017 to 2022
10.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Product, 2023 to 2033
10.3.1. Esophageal Stents
10.3.1.1. Self-Expandable Metal Stents (SEMS)
10.3.1.2. Self-Expandable Plastic Stents (SEPS)
10.3.2. Magnetic Sphincter Augmentation (MSA) Devices
10.3.3. Injectable Bulking Agents
10.3.4. Artificial Esophageal Valves
10.3.4.1. Endoscopic Esophageal Valves
10.3.4.2. Prosthetic Esophageal Valves
10.4. Market Attractiveness Analysis By Product
11. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Application
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Million) Analysis By Application, 2017 to 2022
11.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Application, 2023 to 2033
11.3.1. Gastroesophageal Reflux Disease (GERD)
11.3.2. Esophageal Strictures
11.3.3. Esophageal Fistulas
11.3.4. Esophageal Defects
11.3.5. Weakened Esophageal Sphincters
11.4. Market Attractiveness Analysis By Application
12. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By End User
12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Million) Analysis By End User, 2017 to 2022
12.3. Current and Future Market Size (US$ Million) Analysis and Forecast By End User, 2023 to 2033
12.3.1. Hospitals
12.3.2. Ambulatory Surgical Centers
12.3.3. Specialty Clinics
12.3.4. Academic & Research Institutions
12.4. Market Attractiveness Analysis By End User
13. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by Region
13.1. Introduction
13.2. Historical Market Size (US$ Million) Analysis By Region, 2017 to 2022
13.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Region, 2023 to 2033
13.3.1. North America
13.3.2. Latin America
13.3.3. Europe
13.3.4. South Asia
13.3.5. East Asia
13.3.6. Oceania
13.3.7. Middle East and Africa
13.4. Market Attractiveness Analysis By Region
14. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033
14.1. Introduction
14.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022
14.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
14.3.1. By Country
14.3.1.1. United States
14.3.1.2. Canada
14.3.2. By Product
14.3.3. By Application
14.3.4. By End User
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Product
14.4.3. By Application
14.4.4. By End User
14.5. Country-Level Analysis & Forecast
14.5.1. United States Market Analysis
14.5.1.1. .Introduction
14.5.1.2. Market Analysis and Forecast by Market Taxonomy
14.5.1.2.1. By Product
14.5.1.2.2. By Application
14.5.1.2.3. By End User
14.5.2. Canada Market Analysis
14.5.2.1. Introduction
14.5.2.2. Market Analysis and Forecast by Market Taxonomy
14.5.2.2.1. By Product
14.5.2.2.2. By Application
14.5.2.2.3. By End User
14.6. Market Trends
14.7. Key Market Participants - Intensity Mapping
14.8. Drivers and Restraints - Impact Analysis
15. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033
15.1. Introduction
15.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022
15.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
15.3.1. By Country
15.3.1.1. Brazil
15.3.1.2. Mexico
15.3.1.3. Argentina
15.3.1.4. Rest of Latin America
15.3.2. By Product
15.3.3. By Application
15.3.4. By End User
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Product
15.4.3. By Application
15.4.4. By End User
15.5. Country-Level Analysis & Forecast
15.5.1. Brazil Market Analysis
15.5.1.1. .Introduction
15.5.1.2. Market Analysis and Forecast by Market Taxonomy
15.5.1.2.1. By Product
15.5.1.2.2. By Application
15.5.1.2.3. By End User
15.5.2. Mexico Market Analysis
15.5.2.1. Introduction
15.5.2.2. Market Analysis and Forecast by Market Taxonomy
15.5.2.2.1. By Product
15.5.2.2.2. By Application
15.5.2.2.3. By End User
15.5.3. Argentina Market Analysis
15.5.3.1. Introduction
15.5.3.2. Market Analysis and Forecast by Market Taxonomy
15.5.3.2.1. By Product
15.5.3.2.2. By Application
15.5.3.2.3. By End User
15.6. Market Trends
15.7. Key Market Participants - Intensity Mapping
15.8. Drivers and Restraints - Impact Analysis
16. Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033
16.1. Introduction
16.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022
16.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
16.3.1. By Country
16.3.1.1. Germany
16.3.1.2. France
16.3.1.3. Italy
16.3.1.4. United Kingdom
16.3.1.5. Spain
16.3.1.6. Russia
16.3.1.7. BENELUX
16.3.1.8. Rest of Europe
16.3.2. By Product
16.3.3. By Application
16.3.4. By End User
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Product
16.4.3. By Application
16.4.4. By End User
16.5. Country-Level Analysis & Forecast
16.5.1. Germany Market Analysis
16.5.1.1. .Introduction
16.5.1.2. Market Analysis and Forecast by Market Taxonomy
16.5.1.2.1. By Product
16.5.1.2.2. By Application
16.5.1.2.3. By End User
16.5.2. France Market Analysis
16.5.2.1. Introduction
16.5.2.2. Market Analysis and Forecast by Market Taxonomy
16.5.2.2.1. By Product
16.5.2.2.2. By Application
16.5.2.2.3. By End User
16.5.3. Italy Market Analysis
16.5.3.1. Introduction
16.5.3.2. Market Analysis and Forecast by Market Taxonomy
16.5.3.2.1. By Product
16.5.3.2.2. By Application
16.5.3.2.3. By End User
16.5.4. United Kingdom Market Analysis
16.5.4.1. .Introduction
16.5.4.2. Market Analysis and Forecast by Market Taxonomy
16.5.4.2.1. By Product
16.5.4.2.2. By Application
16.5.4.2.3. By End User
16.5.5. Spain Market Analysis
16.5.5.1. .Introduction
16.5.5.2. Market Analysis and Forecast by Market Taxonomy
16.5.5.2.1. By Product
16.5.5.2.2. By Application
16.5.5.2.3. By End User
16.5.6. Russia Market Analysis
16.5.6.1. .Introduction
16.5.6.2. Market Analysis and Forecast by Market Taxonomy
16.5.6.2.1. By Product
16.5.6.2.2. By Application
16.5.6.2.3. By End User
16.5.7. BENELUX Market Analysis
16.5.7.1. .Introduction
16.5.7.2. Market Analysis and Forecast by Market Taxonomy
16.5.7.2.1. By Product
16.5.7.2.2. By Application
16.5.7.2.3. By End User
16.6. Market Trends
16.7. Key Market Participants - Intensity Mapping
16.8. Drivers and Restraints - Impact Analysis
17. South Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033
17.1. Introduction
17.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022
17.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
17.3.1. By Country
17.3.1.1. India
17.3.1.2. Thailand
17.3.1.3. Indonesia
17.3.1.4. Malaysia
17.3.1.5. Rest of South Asia
17.3.2. By Product
17.3.3. By Application
17.3.4. By End User
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Product
17.4.3. By Application
17.4.4. By End User
17.5. Country-Level Analysis & Forecast
17.5.1. India Market Analysis
17.5.1.1. .Introduction
17.5.1.2. Market Analysis and Forecast by Market Taxonomy
17.5.1.2.1. By Product
17.5.1.2.2. By Application
17.5.1.2.3. By End User
17.5.2. Thailand Market Analysis
17.5.2.1. .Introduction
17.5.2.2. Market Analysis and Forecast by Market Taxonomy
17.5.2.2.1. By Product
17.5.2.2.2. By Application
17.5.2.2.3. By End User
17.5.3. Indonesia Market Analysis
17.5.3.1. Introduction
17.5.3.2. Market Analysis and Forecast by Market Taxonomy
17.5.3.2.1. By Product
17.5.3.2.2. By Application
17.5.3.2.3. By End User
17.5.4. Malaysia Market Analysis
17.5.4.1. Introduction
17.5.4.2. Market Analysis and Forecast by Market Taxonomy
17.5.4.2.1. By Product
17.5.4.2.2. By Application
17.5.4.2.3. By End User
17.6. Market Trends
17.7. Key Market Participants - Intensity Mapping
17.8. Drivers and Restraints - Impact Analysis
18. East Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033
18.1. Introduction
18.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022
18.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
18.3.1. By Country
18.3.1.1. China
18.3.1.2. Japan
18.3.1.3. South Korea
18.3.2. By Product
18.3.3. By Application
18.3.4. By End User
18.4. Market Attractiveness Analysis
18.4.1. By Country
18.4.2. By Product
18.4.3. By Application
18.4.4. By End User
18.5. Country-Level Analysis & Forecast
18.5.1. China Market Analysis
18.5.1.1. .Introduction
18.5.1.2. Market Analysis and Forecast by Market Taxonomy
18.5.1.2.1. By Product
18.5.1.2.2. By Application
18.5.1.2.3. By End User
18.5.2. Japan Market Analysis
18.5.2.1. Introduction
18.5.2.2. Market Analysis and Forecast by Market Taxonomy
18.5.2.2.1. By Product
18.5.2.2.2. By Application
18.5.2.2.3. By End User
18.5.3. South Korea Market Analysis
18.5.3.1. Introduction
18.5.3.2. Market Analysis and Forecast by Market Taxonomy
18.5.3.2.1. By Product
18.5.3.2.2. By Application
18.5.3.2.3. By End User
18.6. Market Trends
18.7. Key Market Participants - Intensity Mapping
18.8. Drivers and Restraints - Impact Analysis
19. Oceania Market Analysis 2017 to 2022 and Forecast 2023 to 2033
19.1. Introduction
19.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022
19.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
19.3.1. By Country
19.3.1.1. Australia
19.3.1.2. New Zealand
19.3.2. By Product
19.3.3. By Application
19.3.4. By End User
19.4. Market Attractiveness Analysis
19.4.1. By Country
19.4.2. By Product
19.4.3. By Application
19.4.4. By End User
19.5. Country-Level Analysis & Forecast
19.5.1. Australia Market Analysis
19.5.1.1. .Introduction
19.5.1.2. Market Analysis and Forecast by Market Taxonomy
19.5.1.2.1. By Product
19.5.1.2.2. By Application
19.5.1.2.3. By End User
19.5.2. New Zealand Market Analysis
19.5.2.1. Introduction
19.5.2.2. Market Analysis and Forecast by Market Taxonomy
19.5.2.2.1. By Product
19.5.2.2.2. By Application
19.5.2.2.3. By End User
19.6. Market Trends
19.7. Key Market Participants - Intensity Mapping
19.8. Drivers and Restraints - Impact Analysis
20. Middle East and Africa Market Analysis 2017 to 2022 and Forecast 2023 to 2033
20.1. Introduction
20.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022
20.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
20.3.1. By Country
20.3.1.1. GCC Countries
20.3.1.2. Türkiye
20.3.1.3. Northern Africa
20.3.1.4. South Africa
20.3.1.5. Rest of Middle East and Africa
20.3.2. By Product
20.3.3. By Application
20.3.4. By End User
20.4. Market Attractiveness Analysis
20.4.1. By Country
20.4.2. By Product
20.4.3. By Application
20.4.4. By End User
20.5. Country-Level Analysis & Forecast
20.5.1. GCC Countries Market Analysis
20.5.1.1. .Introduction
20.5.1.2. Market Analysis and Forecast by Market Taxonomy
20.5.1.2.1. By Product
20.5.1.2.2. By Application
20.5.1.2.3. By End User
20.5.2. Türkiye Market Analysis
20.5.2.1. Introduction
20.5.2.2. Market Analysis and Forecast by Market Taxonomy
20.5.2.2.1. By Product
20.5.2.2.2. By Application
20.5.2.2.3. By End User
20.5.3. Northern Africa Market Analysis
20.5.3.1. Introduction
20.5.3.2. Market Analysis and Forecast by Market Taxonomy
20.5.3.2.1. By Product
20.5.3.2.2. By Application
20.5.3.2.3. By End User
20.5.4. South Africa Market Analysis
20.5.4.1. Introduction
20.5.4.2. Market Analysis and Forecast by Market Taxonomy
20.5.4.2.1. By Product
20.5.4.2.2. By Application
20.5.4.2.3. By End User
20.6. Market Trends
20.7. Key Market Participants - Intensity Mapping
20.8. Drivers and Restraints - Impact Analysis
21. Market Structure Analysis
21.1. Market Analysis by Tier of Companies
21.2. Market Share Analysis of Top Players
21.3. Market Presence Analysis
22. Competition Analysis
22.1. Competition Dashboard
22.2. Branding and Promotional Strategies, By Key Players
22.3. Key Development Analysis
22.4. Competition Deep Dive
22.4.1. Boston Scientific
22.4.1.1. Overview
22.4.1.2. Product Portfolio
22.4.1.3. Key Financials
22.4.1.4. Sales Footprint
22.4.1.5. SWOT Analysis
22.4.1.6. Strategy Overview
22.4.1.6.1. Marketing Strategy
22.4.1.6.2. Product Strategy
22.4.1.6.3. Channel Strategy
22.4.2. Medtronic
22.4.2.1. Overview
22.4.2.2. Product Portfolio
22.4.2.3. Key Financials
22.4.2.4. Sales Footprint
22.4.2.5. SWOT Analysis
22.4.2.6. Strategy Overview
22.4.2.6.1. Marketing Strategy
22.4.2.6.2. Product Strategy
22.4.2.6.3. Channel Strategy
22.4.3. Cook Medical
22.4.3.1. Overview
22.4.3.2. Product Portfolio
22.4.3.3. Key Financials
22.4.3.4. Sales Footprint
22.4.3.5. SWOT Analysis
22.4.3.6. Strategy Overview
22.4.3.6.1. Marketing Strategy
22.4.3.6.2. Product Strategy
22.4.3.6.3. Channel Strategy
22.4.4. Taewoong Medical
22.4.4.1. Overview
22.4.4.2. Product Portfolio
22.4.4.3. Key Financials
22.4.4.4. Sales Footprint
22.4.4.5. SWOT Analysis
22.4.4.6. Strategy Overview
22.4.4.6.1. Marketing Strategy
22.4.4.6.2. Product Strategy
22.4.4.6.3. Channel Strategy
22.4.5. Micro-Tech (Nanjing) Co., Ltd.
22.4.6. Ella-CS
22.4.6.1. Overview
22.4.6.2. Product Portfolio
22.4.6.3. Key Financials
22.4.6.4. Sales Footprint
22.4.6.5. SWOT Analysis
22.4.6.6. Strategy Overview
22.4.6.6.1. Marketing Strategy
22.4.6.6.2. Product Strategy
22.4.6.6.3. Channel Strategy
22.4.7. M.I. Tech
22.4.7.1. Overview
22.4.7.2. Product Portfolio
22.4.7.3. Key Financials
22.4.7.4. Sales Footprint
22.4.7.5. SWOT Analysis
22.4.7.6. Strategy Overview
22.4.7.6.1. Marketing Strategy
22.4.7.6.2. Product Strategy
22.4.7.6.3. Channel Strategy
22.4.8. Merit Medical
22.4.8.1. Overview
22.4.8.2. Product Portfolio
22.4.8.3. Key Financials
22.4.8.4. Sales Footprint
22.4.8.5. SWOT Analysis
22.4.8.6. Strategy Overview
22.4.8.6.1. Marketing Strategy
22.4.8.6.2. Product Strategy
22.4.8.6.3. Channel Strategy
22.4.9. Xlumena Inc.
22.4.9.1. Overview
22.4.9.2. Product Portfolio
22.4.9.3. Key Financials
22.4.9.4. Sales Footprint
22.4.9.5. SWOT Analysis
22.4.9.6. Strategy Overview
22.4.9.6.1. Marketing Strategy
22.4.9.6.2. Product Strategy
22.4.9.6.3. Channel Strategy
22.4.10. Olympus Corporation
22.4.10.1. Overview
22.4.10.2. Product Portfolio
22.4.10.3. Key Financials
22.4.10.4. Sales Footprint
22.4.10.5. SWOT Analysis
22.4.10.6. Strategy Overview
22.4.10.6.1. Marketing Strategy
22.4.10.6.2. Product Strategy
22.4.10.6.3. Channel Strategy
22.4.11. Johnson & Johnson
22.4.11.1. Overview
22.4.11.2. Product Portfolio
22.4.11.3. Key Financials
22.4.11.4. Sales Footprint
22.4.11.5. SWOT Analysis
22.4.11.6. Strategy Overview
22.4.11.6.1. Marketing Strategy
22.4.11.6.2. Product Strategy
22.4.11.6.3. Channel Strategy
22.4.12. Apollo Endosurgery, Inc.
22.4.12.1. Overview
22.4.12.2. Product Portfolio
22.4.12.3. Key Financials
22.4.12.4. Sales Footprint
22.4.12.5. SWOT Analysis
22.4.12.6. Strategy Overview
22.4.12.6.1. Marketing Strategy
22.4.12.6.2. Product Strategy
22.4.12.6.3. Channel Strategy
22.4.13. EndoStim
22.4.13.1. Overview
22.4.13.2. Product Portfolio
22.4.13.3. Key Financials
22.4.13.4. Sales Footprint
22.4.13.5. SWOT Analysis
22.4.13.6. Strategy Overview
22.4.13.6.1. Marketing Strategy
22.4.13.6.2. Product Strategy
22.4.13.6.3. Channel Strategy
22.4.14. NDO Surgical, Inc
22.4.14.1. Overview
22.4.14.2. Product Portfolio
22.4.14.3. Key Financials
22.4.14.4. Sales Footprint
22.4.14.5. SWOT Analysis
22.4.14.6. Strategy Overview
22.4.14.6.1. Marketing Strategy
22.4.14.6.2. Product Strategy
22.4.14.6.3. Channel Strategy
22.4.15. Mederi Therapeutics
22.4.15.1. Overview
22.4.15.2. Product Portfolio
22.4.15.3. Key Financials
22.4.15.4. Sales Footprint
22.4.15.5. SWOT Analysis
22.4.15.6. Strategy Overview
22.4.15.6.1. Marketing Strategy
22.4.15.6.2. Product Strategy
22.4.15.6.3. Channel Strategy
22.4.16. Becton Dickenson & Company
22.4.16.1. Overview
22.4.16.2. Product Portfolio
22.4.16.3. Key Financials
22.4.16.4. Sales Footprint
22.4.16.5. SWOT Analysis
22.4.16.6. Strategy Overview
22.4.16.6.1. Marketing Strategy
22.4.16.6.2. Product Strategy
22.4.16.6.3. Channel Strategy
22.4.17. Baxter International (Synovis Surgical Innovations)
22.4.17.1. Overview
22.4.17.2. Product Portfolio
22.4.17.3. Key Financials
22.4.17.4. Sales Footprint
22.4.17.5. SWOT Analysis
22.4.17.6. Strategy Overview
22.4.17.6.1. Marketing Strategy
22.4.17.6.2. Product Strategy
22.4.17.6.3. Channel Strategy
23. Assumptions and Acronyms Used
24. Research Methodology
Explore Healthcare Insights
View Reports
Esophageal Implant Market
